Oxidativer Stress & Kardiovaskuläre Erkrankungen

Produktname	MDA-oxLDL
	MDA-oxidiertes Low Density Lipoprotein
Kat-Nr.	BI-20022
Bereich	0 – 10 µg/ml
Sensitivität	0.3 µg/ml
Inkubationszeit	23.5 h
Probenmenge	20 µl
Probentyp	Serum, Plasma (Citrat, EDTA oder Heparin)
Probenvorbereitung	Frisch abgenommenes Blut so bald wie möglich zentrifugieren. Aliquotierte Proben bei -25°C oder kälter lagern. Maximal 4 Gefrier- und Auftauzyklen.
Spezies	Human
Tests	96
Methode	ELISA
Produktinformation	- Testvorschrift (pdf-File 596 kb) - Information: The Oxidative Stress&Atherosclerosis Product Line (pdf-File 1752 kb)
Anwendung	Oxidatively modified lipoproteins (ox-LDLs) play an important role in the progression of atherosclerosis and coronary artery disease. Low-density lipoprotein (LDL), the main carrier of plasma cholesterol, consists of a hydrophobic core and a surface monolayer of polar lipids and Apolipoprotein-B (ApoB). Oxidative stress and the consequent formation of free radicals lead to the peroxidation of ApoB. Malondialdehyde (MDA) has been identifiedas one of the major lipid peroxidation products of LDL, thus playing an important role in the LDL oxidation. The MDA ox-LDL ELISA specifically detects MDA-modified Apo B in human serum and plasma.